RSS

Aptalis Pharmaceutical Technologies

Aptalis Pharmaceutical Technologies has been divested from Actavis to TPG, a global private investment firm, has been completed. more

News

Aptalis Pharmaceutical Technologies is known for overcoming even the most demanding oral drug delivery challenges. The company’s comprehensive portfolio of oral drug delivery technologies for bioavailability enhancement, custom release profiles... more

News

Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing patient-optimised oral products utilising its proprietary pharmaceutical technologies and development expertise, has announced its co-sponsorship of... more

Technology

Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that develops differentiated products utilising its oral delivery technologies, has announced that Nigel Ray has been named as the company’s Vice President of Global Licensing. more

Technology

Aptalis Pharmaceutical Technologies has announced that the European Commission granted marketing authorisation for a new paediatric indication of a new oral granule formulation of Gilead Sciences, Inc.’s Viread for HIV infected children... more

Technology